Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tyrosine-mediated metabolic pathway encompasses the biosynthesis, catabolism, and transformation of the amino acid tyrosine into a wide array of biologically significant molecules. Tyrosine is a precursor for catecholamine neurotransmitters, thyroid hormones, melanin pigment, and coenzyme Q10. The pathway integrates with energy metabolism through fumarate and acetoacetate. Disorders affecting this pathway include inherited enzyme deficiencies such as phenylketonuria and alkaptonuria, leading to accumulation or deficiency of key intermediates/metabolites with clinical consequences.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-Mediated Metabolic Pathway (N/A).